ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Members of the primary biliary cholangitis (PBC) community have come together in September as part of PBC Awareness Month to...
TOPLINE:Patients living more than 150 km from a liver transplant center had similar waitlist mortality and transplant rates as those...
NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- Evergreen Nephrology, a leader in value-based kidney care, today announced it has raised $130...
Help shape the future of women's health by taking the survey and supporting this global campaign in its eleventh year...
Help shape the future of women's health by taking the survey and supporting this global campaign in its eleventh year...